Trial Information - Phase III
A PHASE 3, OPEN-LABEL, 3-COHORTRANDOMIZED STUDY OF N-803 IN COMBINATIONWITH CURRENT STANDARD OF CARE VS STANDARDOF CARE AS FIRST-LINE TREATMENT FORPATIENTS WITH ADVANCED OR METASTATICNON-SMALL CELL LUNG CANCER
Disease Specifics: NSCLC
Protocol ID: QUILT-2.023
Sponsor: Immunity Bio
Status: STUDY ON HOLD
Contact us regarding Clinical Trials at MOHRSCH@usoncology.com
or call us at
877-664-7724
